Brimonidine eye drops
قطره چشمی بریمونیدین
👁️ Sensory Organsα2 agonist (IOP-lowering)
Market / country: 🇺🇸 USA
Alphagan P (US)
🧮 Dose calculator
Open-angle glaucoma / ocular hypertension · Regimen source: FDA Brimonidine 0.1% · 2
- • At least 5 minutes apart from other eye drops. FDA Brimonidine 0.1% · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Neonates and infants under 2 years. FDA Brimonidine 0.1% · 4
- ⛔ Previous hypersensitivity reaction. FDA Brimonidine 0.1% · 4
Formulations
- Brimonidine tartrate 0.1% eye drops — eye drops 🇺🇸 USA FDA Brimonidine 0.1% · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Brimonidine 0.1% · 8.1
“Risk Summary There are no adequate and well-controlled studies with brimonidine tartrate ophthalmic solution in pregnant women.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Brimonidine 0.1% · 8.2
“In animal studies, brimonidine tartrate has been shown to cross the blood-brain barrier and is excreted into breast milk after oral administration to lactating rats (see Data) .”
- 👶 ChildrenUse with caution
Label: contraindicated under 2 years; use with caution from 2 years. FDA Brimonidine 0.1% · 4
“Neonates and infants (pediatric patients younger than 2 years old).”
- 👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. FDA Brimonidine 0.1% · 8.5
“No overall differences in safety or effectiveness have been observed between elderly and other adult patients.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA220398
- DailyMed (FDA label)FDA Brimonidine 0.1%
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDS01EA05
- Darooyab (Iran)Brimonidine
🇮🇷 Registered in Iran Darooyab · G-1565/Brimonidine
Dosage forms with Iranian generic codes, per Darooyab.
- 18369 · BRIMONIDINE 1.3 MG +TIMOLOL 0.5 MG DROP · قطره بریمونیدین ۱٫۳ میلیگرم + تیمولول ۰٫۵ میلیگرم
- 11459 · BRIMONIDINE TARTRATE 0.2% OPH DROP · قطره چشمی بریمونیدین تارتارات ۰٫۲ درصد
- 02028 · BRIMONIDINE TARTRATE 1% 5ML OPH DROP · قطره چشمی بریمونیدین تارتارات ۱ درصد ۵ میلیلیتر
- 52430 · BRIMONIDINE (AS TARTRATE) GEL TOPICAL 3 mg/1g 30 g · ژل موضعی بریمونیدین (معادل تارتارات) ۳ میلیگرم / ۱ گرم ۳۰ گرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Brimonidine 0.1% · 3FDA Brimonidine 0.1% · 2FDA Brimonidine 0.1% · 4FDA Brimonidine 0.1% · 8.1FDA Brimonidine 0.1% · 8.2FDA Brimonidine 0.1% · 8.5FDA Brimonidine 0.1% · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1565/Brimonidine
- Clinical review⚠ Unverified